Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview

[1]  E. Dekker,et al.  Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  B. V. Pedersen,et al.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. , 2012, Gastroenterology.

[3]  T. Graham,et al.  Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. , 2012, Gastroenterology.

[4]  D. Hommes,et al.  Misclassification of dysplasia in patients with inflammatory bowel disease: Consequences for progression rates to advanced neoplasia , 2011, Inflammatory bowel diseases.

[5]  F. Vleggaar,et al.  Endoscopic and pathological aspects of colitis-associated dysplasia , 2009, Nature Reviews Gastroenterology &Hepatology.

[6]  J. Askling,et al.  Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. , 2009, Gastroenterology.

[7]  N. Shepherd,et al.  Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. , 2009, Gastroenterology.

[8]  N. Harpaz,et al.  Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  N. Harpaz,et al.  Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial , 2008, The American Journal of Gastroenterology.

[10]  S. Cross,et al.  Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? , 2006, Gut.

[11]  A. Forbes,et al.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.

[12]  M. Vieth,et al.  Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment , 2005, Gut.

[13]  R. Kiesslich,et al.  Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. , 2004, Endoscopy.

[14]  R. Odze,et al.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  A. Forbes,et al.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis , 2004, Gut.

[16]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[17]  Bernhard Nafe,et al.  Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2003, Gastroenterology.

[18]  J. Goldblum,et al.  Interobserver Variability in the Diagnosis of Ulcerative Colitis-Associated Dysplasia by Telepathology , 2002, Modern Pathology.

[19]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[20]  N. Harpaz,et al.  Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. , 1999, Gastroenterology.

[21]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[22]  M. Kamm,et al.  Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. , 1994, Gut.

[23]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[24]  R. Haggitt,et al.  Cancer surveillance in ulcerative colitis. , 1991, Gastroenterology.

[25]  D. Sachar,et al.  A Comparison of Multiple Synchronous Colorectal Cancer in Ulcerative Colitis, Familial Polyposis Coli, and de Novo Cancer , 1986, Annals of surgery.

[26]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[27]  M. Picco Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease , 2009 .

[28]  B. Levin,et al.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. , 1981, Gastroenterology.